摘要
背景:感染人乳头状瘤病毒(HPV)引起多种恶性肿瘤,约占人类癌症的10-20%。最近开发的两种预防病毒感染的疫苗具有很强的免疫原性,可以提供长期保护。这些疫苗的使用大大降低了全世界妇女第二常见的癌症宫颈的发病率。然而,治疗疫苗可以消除已经存在的人乳头状瘤病毒感染和治疗现有的人乳头状瘤病毒引起的癌症,但是这些疫苗尚未开发。 方法:在这个简单的综述中,我们讨论了人乳头状瘤病毒相关癌症的免疫疗法和对人乳头状瘤病毒感染的免疫病理学的认识的进展。 结果:最近的研究进展表明,人乳头状瘤病毒感染引起的癌症以分子生物学方法靶向免疫治疗对于免疫治疗疫苗的开发有很大的潜力和前景。到目前为止,所测试的免疫疫苗绝大多数是针对人乳头状瘤病毒病毒的基因及其蛋白,尤其是E6和E7癌基因。 结论:发展的免疫疫苗的目的是提高细胞免疫功能,增强的细胞免疫就增强了机体抵御疾病和机体的自然防御能力,从而治疗现有的癌症。
关键词: 免疫治疗,人乳头状瘤病毒,免疫病理机制,癌症,病毒感染,免疫原性,免疫治疗。
图形摘要
Current Cancer Drug Targets
Title:Molecular Approaches Target to Immunotherapy for HPV-Associated Cancers
Volume: 17 Issue: 6
关键词: 免疫治疗,人乳头状瘤病毒,免疫病理机制,癌症,病毒感染,免疫原性,免疫治疗。
摘要: Background: Infection with human papillomavirus (HPVs) causes many cancers, which account for about 10-20% of total human cancers. Two recently developed prophylactic vaccines against virus infection confer strong immunogenicity to provide long-term protection. The use of these vaccines has contributed to a substantial decrease in the rates of cervical cancer the second most common cancer of women worldwide. However, therapeutic vaccines that can eliminate preexisting HPV infections and treat an existing HPV-caused cancer have not been developed.
Method: In this short review, we discuss development of immunotherapy for HPV-associated cancers and recent progresses in our understanding of the immunopathology of HPV infection. Results: Recent research advances have shown that molecular approaches target to immunotherapy for HPV infection-induced cancers to have the great potential and promise for developing immunotherapeutic vaccines. So far, the vast majority of the immunotherapeutic vaccines that are being tested are designed to target HPV viral genes and their proteins especially two E6 and E7 oncogenes. Conclusion: The developing immunotherapeutic vaccines aim to boost cell-mediated immunity. The boosted cell-mediated immunity strengthens the body’s natural defenses to fight active infection and disease, thus to treat the existing cancers.Export Options
About this article
Cite this article as:
Molecular Approaches Target to Immunotherapy for HPV-Associated Cancers, Current Cancer Drug Targets 2017; 17 (6) . https://dx.doi.org/10.2174/1568009616666161216094701
DOI https://dx.doi.org/10.2174/1568009616666161216094701 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Theranostics Based on Iron Oxide and Gold Nanoparticles for Imaging- Guided Photothermal and Photodynamic Therapy of Cancer
Current Topics in Medicinal Chemistry Potentials and Challenges of Active Targeting at the Tumor Cells by Engineered Polymeric Nanoparticles
Current Pharmaceutical Biotechnology Exploiting Protein Phosphatase Inhibitors Based on Cantharidin Analogues for Cancer Drug Discovery
Mini-Reviews in Medicinal Chemistry Potential Cancer Gene Therapy by Baculoviral Transduction
Current Gene Therapy VDAC1 as a Player in Mitochondria-Mediated Apoptosis and Target for Modulating Apoptosis
Current Medicinal Chemistry Plants vs. Cancer: A Review on Natural Phytochemicals in Preventing and Treating Cancers and Their Druggability
Anti-Cancer Agents in Medicinal Chemistry Rediscovering the Antibiotics of the Hive
Recent Patents on Anti-Infective Drug Discovery CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review
Protein & Peptide Letters Obstetrician-Gynecologists’ Practices, Statistical Literacy, and Risk Communication with Regard to Sexually Transmitted Infections
Current HIV Research Viral and Non-Viral Methods to Genetically Modify Dendritic Cells
Current Gene Therapy Biomedical Applications of Carbon Nanotubes: A Critical Review
Current Drug Delivery Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies
Current Cancer Drug Targets Biomarkers for Cancers in Women: Present Status and Future Perspectives
Current Women`s Health Reviews Doxorubicin Sensitizes the Non-Small Cell Lung Cancer Cells to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated (TRAIL) Apoptosis In Vitro but not In Vivo
Letters in Drug Design & Discovery An Epigenetic Approach to Pancreatic Cancer Treatment: The Prospective Role of Histone Deacetylase Inhibitors
Current Cancer Drug Targets Polyphenols Counteract Tumor Cell Chemoresistance Conferred by Multidrug Resistance Proteins
Anti-Cancer Agents in Medicinal Chemistry Th17 and Treg Cells, Two New Lymphocyte Subpopulations with a Key Role in the Immune Response Against Infection
Infectious Disorders - Drug Targets Coexistence of Hodgkin and Non-Hodgkin Lymphoma; Composite Lymphoma [CL] in a Patient Presenting with Waxing and Waning Lymphadenopathy
Cardiovascular & Hematological Disorders-Drug Targets The Screening of Renoprotective Agents by 99mTc-DMSA: A Review of Preclinical Studies
Current Radiopharmaceuticals The Mechanism of Adjuvanticity of Aluminium-Containing Formulas
Current Pharmaceutical Design